Publication | Closed Access

Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. results from a six-year study (1996–2001)

Antifungal AgentHealth SciencesFungal PathogenAntifungal AgentsVitro SusceptibilitiesMedicineCandida Bloodstream IsolatesMedicinal FungiClinical MycologyAntimicrobial PharmacokineticsMicrobiologyPharmacologyClinical MicrobiologyAntimicrobial ResistanceSix-year StudyDrug Resistance